Predictors of distant metastatic recurrence in head and neck cutaneous squamous cell carcinoma with lymph node metastases treated with curative intent: A multicenter study

Ardalan Ebrahimi; Ruta Gupta; Lachlan McDowell; Matthew J.R. Magarey; Paul N. Smith; Klaus Martin Schulte; Diana M. Perriman; Michael Veness; Sandro Porceddu; Tsu Hui Hubert Low; Allan Fowler; Jonathan R. Clark

doi:10.1002/hed.27912

Predictors of distant metastatic recurrence in head and neck cutaneous squamous cell carcinoma with lymph node metastases treated with curative intent: A multicenter study

Ardalan Ebrahimi^*, Ruta Gupta, Lachlan McDowell, Matthew J.R. Magarey, Paul N. Smith, Klaus Martin Schulte, Diana M. Perriman, Michael Veness, Sandro Porceddu, Tsu Hui Hubert Low, Allan Fowler, Jonathan R. Clark

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

Background: We aimed to identify predictors of distant metastatic recurrence (DMR) in patients with head and neck cutaneous squamous cell carcinoma (HNcSCC) with nodal metastases treated with curative intent. Methods: Predictors of DMR were identified using Cox regression in a multicenter study of 1151 patients. Results: The 5-year risk of DMR was 9.6%. On multivariate analysis, immunosuppression (HR 2.93; 95% CI: 1.70–5.05; p < 0.001), nodal size >6 cm [versus ≤3 cm (HR 2.77; 95% CI: 1.09–7.03; p = 0.032)], ≥5 nodal metastases [versus 1–2 (HR 2.79; 95% CI: 1.63–4.78; p < 0.001)], and bilateral disease (HR 3.11; 95% CI: 1.40–6.90; p = 0.005) predicted DMR. A DMR risk score was developed that stratified risk from 6.6% (no risk factors) to 100% (≥3 risk factors) (p < 0.001). Conclusions: The risk of DMR in nodal metastatic HNcSCC increases with immunosuppression, nodal size >6 cm, ≥5 nodal metastases, and bilateral disease. A simple DMR risk score estimated prior to treatment may be clinically useful.

Original language	English
Journal	Head and Neck
DOIs	https://doi.org/10.1002/hed.27912
Publication status	Accepted/In press - 2024
Externally published	Yes

Access to Document

10.1002/hed.27912

Cite this

Ebrahimi, A., Gupta, R., McDowell, L., Magarey, M. J. R., Smith, P. N., Schulte, K. M., Perriman, D. M., Veness, M., Porceddu, S., Low, T. H. H., Fowler, A., & Clark, J. R. (Accepted/In press). Predictors of distant metastatic recurrence in head and neck cutaneous squamous cell carcinoma with lymph node metastases treated with curative intent: A multicenter study. Head and Neck. https://doi.org/10.1002/hed.27912

@article{9e8be54cef1e48a282a552b22df40de3,

title = "Predictors of distant metastatic recurrence in head and neck cutaneous squamous cell carcinoma with lymph node metastases treated with curative intent: A multicenter study",

abstract = "Background: We aimed to identify predictors of distant metastatic recurrence (DMR) in patients with head and neck cutaneous squamous cell carcinoma (HNcSCC) with nodal metastases treated with curative intent. Methods: Predictors of DMR were identified using Cox regression in a multicenter study of 1151 patients. Results: The 5-year risk of DMR was 9.6%. On multivariate analysis, immunosuppression (HR 2.93; 95% CI: 1.70–5.05; p < 0.001), nodal size >6 cm [versus ≤3 cm (HR 2.77; 95% CI: 1.09–7.03; p = 0.032)], ≥5 nodal metastases [versus 1–2 (HR 2.79; 95% CI: 1.63–4.78; p < 0.001)], and bilateral disease (HR 3.11; 95% CI: 1.40–6.90; p = 0.005) predicted DMR. A DMR risk score was developed that stratified risk from 6.6% (no risk factors) to 100% (≥3 risk factors) (p < 0.001). Conclusions: The risk of DMR in nodal metastatic HNcSCC increases with immunosuppression, nodal size >6 cm, ≥5 nodal metastases, and bilateral disease. A simple DMR risk score estimated prior to treatment may be clinically useful.",

keywords = "cutaneous squamous cell carcinoma, distant metastases, head and neck cancer, lymph node metastasis, prognosis",

author = "Ardalan Ebrahimi and Ruta Gupta and Lachlan McDowell and Magarey, {Matthew J.R.} and Smith, {Paul N.} and Schulte, {Klaus Martin} and Perriman, {Diana M.} and Michael Veness and Sandro Porceddu and Low, {Tsu Hui Hubert} and Allan Fowler and Clark, {Jonathan R.}",

note = "Publisher Copyright: {\textcopyright} 2024 The Author(s). Head & Neck published by Wiley Periodicals LLC.",

year = "2024",

doi = "10.1002/hed.27912",

language = "English",

journal = "Head and Neck",

issn = "1043-3074",

publisher = "John Wiley & Sons Inc.",

}

Ebrahimi, A, Gupta, R, McDowell, L, Magarey, MJR, Smith, PN, Schulte, KM, Perriman, DM, Veness, M, Porceddu, S, Low, THH, Fowler, A & Clark, JR 2024, 'Predictors of distant metastatic recurrence in head and neck cutaneous squamous cell carcinoma with lymph node metastases treated with curative intent: A multicenter study', Head and Neck. https://doi.org/10.1002/hed.27912

TY - JOUR

T1 - Predictors of distant metastatic recurrence in head and neck cutaneous squamous cell carcinoma with lymph node metastases treated with curative intent

T2 - A multicenter study

AU - Ebrahimi, Ardalan

AU - Gupta, Ruta

AU - McDowell, Lachlan

AU - Magarey, Matthew J.R.

AU - Smith, Paul N.

AU - Schulte, Klaus Martin

AU - Perriman, Diana M.

AU - Veness, Michael

AU - Porceddu, Sandro

AU - Low, Tsu Hui Hubert

AU - Fowler, Allan

AU - Clark, Jonathan R.

PY - 2024

Y1 - 2024

N2 - Background: We aimed to identify predictors of distant metastatic recurrence (DMR) in patients with head and neck cutaneous squamous cell carcinoma (HNcSCC) with nodal metastases treated with curative intent. Methods: Predictors of DMR were identified using Cox regression in a multicenter study of 1151 patients. Results: The 5-year risk of DMR was 9.6%. On multivariate analysis, immunosuppression (HR 2.93; 95% CI: 1.70–5.05; p < 0.001), nodal size >6 cm [versus ≤3 cm (HR 2.77; 95% CI: 1.09–7.03; p = 0.032)], ≥5 nodal metastases [versus 1–2 (HR 2.79; 95% CI: 1.63–4.78; p < 0.001)], and bilateral disease (HR 3.11; 95% CI: 1.40–6.90; p = 0.005) predicted DMR. A DMR risk score was developed that stratified risk from 6.6% (no risk factors) to 100% (≥3 risk factors) (p < 0.001). Conclusions: The risk of DMR in nodal metastatic HNcSCC increases with immunosuppression, nodal size >6 cm, ≥5 nodal metastases, and bilateral disease. A simple DMR risk score estimated prior to treatment may be clinically useful.

AB - Background: We aimed to identify predictors of distant metastatic recurrence (DMR) in patients with head and neck cutaneous squamous cell carcinoma (HNcSCC) with nodal metastases treated with curative intent. Methods: Predictors of DMR were identified using Cox regression in a multicenter study of 1151 patients. Results: The 5-year risk of DMR was 9.6%. On multivariate analysis, immunosuppression (HR 2.93; 95% CI: 1.70–5.05; p < 0.001), nodal size >6 cm [versus ≤3 cm (HR 2.77; 95% CI: 1.09–7.03; p = 0.032)], ≥5 nodal metastases [versus 1–2 (HR 2.79; 95% CI: 1.63–4.78; p < 0.001)], and bilateral disease (HR 3.11; 95% CI: 1.40–6.90; p = 0.005) predicted DMR. A DMR risk score was developed that stratified risk from 6.6% (no risk factors) to 100% (≥3 risk factors) (p < 0.001). Conclusions: The risk of DMR in nodal metastatic HNcSCC increases with immunosuppression, nodal size >6 cm, ≥5 nodal metastases, and bilateral disease. A simple DMR risk score estimated prior to treatment may be clinically useful.

KW - cutaneous squamous cell carcinoma

KW - distant metastases

KW - head and neck cancer

KW - lymph node metastasis

KW - prognosis

UR - http://www.scopus.com/inward/record.url?scp=85200987869&partnerID=8YFLogxK

U2 - 10.1002/hed.27912

DO - 10.1002/hed.27912

M3 - Article

AN - SCOPUS:85200987869

SN - 1043-3074

JO - Head and Neck

JF - Head and Neck

ER -

Predictors of distant metastatic recurrence in head and neck cutaneous squamous cell carcinoma with lymph node metastases treated with curative intent: A multicenter study

Abstract

Access to Document

Other files and links

Fingerprint

Cite this